Literature DB >> 1422053

Dystrophin: the protein product of the Duchene muscular dystrophy locus. 1987.

E P Hoffman, R H Brown, L M Kunkel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1422053

Source DB:  PubMed          Journal:  Biotechnology        ISSN： 0740-7378


× No keyword cloud information.
  19 in total

1.  Diaphragm remodeling and compensatory respiratory mechanics in a canine model of Duchenne muscular dystrophy.

Authors:  A F Mead; M Petrov; A S Malik; M A Mitchell; M K Childers; J R Bogan; G Seidner; J N Kornegay; H H Stedman
Journal:  J Appl Physiol (1985)       Date:  2014-01-09

2.  Full functional rescue of a complete muscle (TA) in dystrophic hamsters by adeno-associated virus vector-directed gene therapy.

Authors:  X Xiao; J Li; Y P Tsao; D Dressman; E P Hoffman; J F Watchko
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  Life-Long AAV-Mediated CRISPR Genome Editing in Dystrophic Heart Improves Cardiomyopathy without Causing Serious Lesions in mdx Mice.

Authors:  Li Xu; Yeh Siang Lau; Yandi Gao; Haiwen Li; Renzhi Han
Journal:  Mol Ther       Date:  2019-05-15       Impact factor: 11.454

4.  Patterns of left ventricular remodeling in patients with Duchenne Muscular Dystrophy: a cardiac MRI study of ventricular geometry, global function, and strain.

Authors:  Wojciech Mazur; Kan N Hor; Joshua T Germann; Robert J Fleck; Hussein R Al-Khalidi; Janaka P Wansapura; Eugene S Chung; Michael D Taylor; John L Jefferies; D Woodrow Benson; William M Gottliebson
Journal:  Int J Cardiovasc Imaging       Date:  2011-01-08       Impact factor: 2.357

5.  The clinical and molecular genetic approach to Duchenne and Becker muscular dystrophy: an updated protocol.

Authors:  A J van Essen; A L Kneppers; A H van der Hout; H Scheffer; I B Ginjaar; L P ten Kate; G J van Ommen; C H Buys; E Bakker
Journal:  J Med Genet       Date:  1997-10       Impact factor: 6.318

6.  In Vivo Genome Editing Restores Dystrophin Expression and Cardiac Function in Dystrophic Mice.

Authors:  Mona El Refaey; Li Xu; Yandi Gao; Benjamin D Canan; T M Ayodele Adesanya; Sarah C Warner; Keiko Akagi; David E Symer; Peter J Mohler; Jianjie Ma; Paul M L Janssen; Renzhi Han
Journal:  Circ Res       Date:  2017-08-08       Impact factor: 17.367

7.  Independent variability of microtubule perturbations associated with dystrophinopathy.

Authors:  Joseph J Belanto; John T Olthoff; Tara L Mader; Christopher M Chamberlain; D'anna M Nelson; Preston M McCourt; Dana M Talsness; Gregg G Gundersen; Dawn A Lowe; James M Ervasti
Journal:  Hum Mol Genet       Date:  2016-11-15       Impact factor: 6.150

8.  D-Amino Acid Substitution of Peptide-Mediated NF-κB Suppression in mdx Mice Preserves Therapeutic Benefit in Skeletal Muscle, but Causes Kidney Toxicity.

Authors:  Daniel P Reay; Sheldon I Bastacky; Kathryn E Wack; Donna B Stolz; Paul D Robbins; Paula R Clemens
Journal:  Mol Med       Date:  2015-05-22       Impact factor: 6.354

9.  Physical training in boys with Duchenne Muscular Dystrophy: the protocol of the No Use is Disuse study.

Authors:  Merel Jansen; Imelda Jm de Groot; Nens van Alfen; Alexander Ch Geurts
Journal:  BMC Pediatr       Date:  2010-08-06       Impact factor: 2.125

10.  Polymeric nanoparticles functionalized with muscle-homing peptides for targeted delivery of phosphatase and tensin homolog inhibitor to skeletal muscle.

Authors:  Di Huang; Feng Yue; Jiamin Qiu; Meng Deng; Shihuan Kuang
Journal:  Acta Biomater       Date:  2020-10-11       Impact factor: 8.947
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.